Let us help you customize your experience.
Tell us a little about yourself so we can share more relevant content and resources.
Arkansas Children's Hospital is excited to announce that starting June 2020, the SATB2-associated syndrome clinic will be offered quarterly. For more information, please contact the SATB2 clinic coordinator, Katie Bosanko at firstname.lastname@example.org.
SATB2-associated syndrome (SAS) is a genetic disorder characterized by:
Changes in the SATB2 gene cause this syndrome. Common types of gene changes are mutations (misspellings), deletions (pieces missing), or duplications (pieces extra) in the SATB2 gene. SAS has also been labeled “Glass syndrome” (OMIM #612313) after Dr. Glass who described a patient with a deletion in chromosome 2 back in 1989. Similarly, other patients with deletions in this area have been labeled “2q33.1 microdeletion syndrome” or “2q32 deletion syndrome”.
Yuri Zarate, M.D., is a clinical geneticist at Arkansas Children’s Hospital and has initiated a project to collect clinical information on patients with SAS no matter how the SATB2 gene is changed (deletions, duplications, or mutations) to increase knowledge of this condition.
Currently, more than 150 families are enrolled in the study. Parents and clinicians are encouraged to contact Dr. Zarate for further questions and to consider enrollment in his study.
For more information about SATB2, including FAQs, visit: satb2gene.com